Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myometrium | 30 | 2006 | 174 | 3.140 |
Why?
|
Uterine Contraction | 22 | 2009 | 90 | 3.020 |
Why?
|
Parturition | 7 | 2020 | 453 | 2.280 |
Why?
|
Uterus | 15 | 2020 | 660 | 1.960 |
Why?
|
Placenta | 9 | 2022 | 1726 | 1.870 |
Why?
|
Extraembryonic Membranes | 4 | 2019 | 37 | 1.810 |
Why?
|
Obstetric Labor, Premature | 6 | 2022 | 268 | 1.770 |
Why?
|
Progesterone | 3 | 2020 | 751 | 1.300 |
Why?
|
Term Birth | 2 | 2020 | 140 | 1.180 |
Why?
|
Pregnancy, Animal | 10 | 2006 | 124 | 1.160 |
Why?
|
Premature Birth | 7 | 2022 | 1830 | 1.110 |
Why?
|
Telomere | 5 | 2022 | 941 | 1.020 |
Why?
|
Lipopolysaccharides | 6 | 2017 | 2212 | 0.890 |
Why?
|
Pregnancy | 73 | 2022 | 30228 | 0.860 |
Why?
|
Muscle, Smooth | 12 | 2002 | 931 | 0.810 |
Why?
|
Labor, Obstetric | 4 | 2020 | 313 | 0.730 |
Why?
|
Interleukin-10 Receptor beta Subunit | 1 | 2020 | 16 | 0.690 |
Why?
|
Interleukin-10 Receptor alpha Subunit | 1 | 2020 | 28 | 0.680 |
Why?
|
Estradiol | 4 | 2017 | 1947 | 0.680 |
Why?
|
Oxytocin | 11 | 2000 | 403 | 0.670 |
Why?
|
Rats, Sprague-Dawley | 35 | 2009 | 8114 | 0.650 |
Why?
|
Phospholipase C gamma | 3 | 2009 | 130 | 0.640 |
Why?
|
Toll-Like Receptor 9 | 2 | 2017 | 197 | 0.640 |
Why?
|
Thapsigargin | 1 | 2018 | 102 | 0.630 |
Why?
|
Phospholipid Transfer Proteins | 2 | 2012 | 90 | 0.630 |
Why?
|
Gestational Age | 12 | 2022 | 3616 | 0.620 |
Why?
|
Influenza, Human | 3 | 2017 | 1542 | 0.610 |
Why?
|
Thrombin | 4 | 2001 | 600 | 0.610 |
Why?
|
DNA | 4 | 2017 | 7192 | 0.600 |
Why?
|
Type C Phospholipases | 8 | 2001 | 284 | 0.590 |
Why?
|
Interleukin-10 | 2 | 2020 | 1181 | 0.540 |
Why?
|
Toll-Like Receptor 5 | 1 | 2016 | 42 | 0.540 |
Why?
|
Labor Onset | 1 | 2015 | 17 | 0.500 |
Why?
|
Thromboplastin | 3 | 2011 | 289 | 0.500 |
Why?
|
Rats | 39 | 2009 | 23718 | 0.470 |
Why?
|
Orthomyxoviridae Infections | 1 | 2017 | 255 | 0.470 |
Why?
|
Influenza A virus | 1 | 2017 | 455 | 0.430 |
Why?
|
Gene Expression | 7 | 2012 | 7581 | 0.430 |
Why?
|
Fetus | 4 | 2017 | 1878 | 0.420 |
Why?
|
Animals | 73 | 2022 | 168801 | 0.420 |
Why?
|
Orthomyxoviridae | 1 | 2014 | 148 | 0.420 |
Why?
|
Death | 1 | 2017 | 685 | 0.400 |
Why?
|
Isoenzymes | 6 | 2012 | 1688 | 0.390 |
Why?
|
Chemokine CCL2 | 2 | 2016 | 602 | 0.350 |
Why?
|
Urinary Bladder | 1 | 2016 | 1156 | 0.340 |
Why?
|
Blotting, Western | 11 | 2012 | 5019 | 0.340 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2014 | 2184 | 0.340 |
Why?
|
Cytosol | 8 | 2000 | 885 | 0.330 |
Why?
|
Receptors, Adrenergic, alpha | 4 | 1991 | 146 | 0.320 |
Why?
|
Lymphocytes | 1 | 2017 | 2602 | 0.320 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2009 | 93 | 0.320 |
Why?
|
Longevity | 1 | 2017 | 1085 | 0.320 |
Why?
|
Diglycerides | 3 | 2000 | 175 | 0.310 |
Why?
|
Immune System | 1 | 2014 | 799 | 0.310 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 147 | 0.310 |
Why?
|
Dinoprost | 6 | 2001 | 139 | 0.300 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2009 | 457 | 0.290 |
Why?
|
Inflammation | 5 | 2017 | 10858 | 0.290 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 4565 | 0.290 |
Why?
|
Calcium Channels | 4 | 1999 | 622 | 0.290 |
Why?
|
Female | 94 | 2022 | 396174 | 0.290 |
Why?
|
Estrus | 8 | 2006 | 70 | 0.280 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 5 | 2000 | 34 | 0.280 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2000 | 853 | 0.280 |
Why?
|
Calcium | 14 | 2000 | 5770 | 0.270 |
Why?
|
Isometric Contraction | 4 | 2001 | 149 | 0.250 |
Why?
|
Protein Kinase C | 4 | 1999 | 1205 | 0.240 |
Why?
|
Blood Coagulation | 1 | 2011 | 1168 | 0.240 |
Why?
|
Fibrinogen | 2 | 2011 | 894 | 0.230 |
Why?
|
Aluminum Compounds | 5 | 1995 | 56 | 0.230 |
Why?
|
Mice | 14 | 2022 | 81838 | 0.230 |
Why?
|
Ionomycin | 4 | 1997 | 109 | 0.220 |
Why?
|
Biological Clocks | 2 | 2017 | 319 | 0.220 |
Why?
|
Fluorides | 5 | 1995 | 134 | 0.220 |
Why?
|
Platelet Activating Factor | 1 | 2003 | 142 | 0.220 |
Why?
|
Potassium Chloride | 4 | 1997 | 227 | 0.210 |
Why?
|
Apoptosis | 2 | 2018 | 9507 | 0.210 |
Why?
|
Disease Outbreaks | 2 | 2009 | 1761 | 0.210 |
Why?
|
RNA, Messenger | 10 | 2012 | 12772 | 0.210 |
Why?
|
Interleukin-6 | 3 | 2017 | 3227 | 0.210 |
Why?
|
Tyrosine | 1 | 2007 | 1427 | 0.200 |
Why?
|
Proestrus | 5 | 2002 | 14 | 0.200 |
Why?
|
Catecholamines | 5 | 1997 | 388 | 0.200 |
Why?
|
Signal Transduction | 13 | 2018 | 23600 | 0.200 |
Why?
|
Prothrombin | 1 | 2002 | 193 | 0.190 |
Why?
|
Inositol Phosphates | 4 | 2000 | 174 | 0.190 |
Why?
|
Dopamine | 6 | 1987 | 1582 | 0.180 |
Why?
|
Receptors, Adrenergic, beta | 2 | 1992 | 242 | 0.170 |
Why?
|
Nifedipine | 2 | 1997 | 220 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 1 | 2022 | 587 | 0.170 |
Why?
|
Periodicity | 3 | 1998 | 347 | 0.160 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2018 | 68 | 0.160 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2000 | 327 | 0.160 |
Why?
|
Neomycin | 2 | 1997 | 94 | 0.150 |
Why?
|
Magnesium Sulfate | 1 | 1998 | 74 | 0.150 |
Why?
|
Toll-Like Receptors | 2 | 2017 | 582 | 0.150 |
Why?
|
5-Methylcytosine | 1 | 2018 | 146 | 0.150 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18321 | 0.150 |
Why?
|
Boron Compounds | 1 | 1999 | 195 | 0.150 |
Why?
|
Immunohistochemistry | 8 | 2007 | 11035 | 0.140 |
Why?
|
Culture Media, Conditioned | 1 | 2018 | 520 | 0.140 |
Why?
|
Receptor, PAR-1 | 2 | 2011 | 109 | 0.140 |
Why?
|
Muscle Contraction | 2 | 1999 | 1207 | 0.140 |
Why?
|
Dioxolanes | 1 | 1997 | 23 | 0.140 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 1997 | 52 | 0.140 |
Why?
|
Amniotic Fluid | 4 | 1986 | 381 | 0.140 |
Why?
|
GTP-Binding Proteins | 2 | 2000 | 945 | 0.140 |
Why?
|
Muscarinic Agonists | 1 | 1997 | 91 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2000 | 575 | 0.140 |
Why?
|
Ruthenium Red | 1 | 1996 | 19 | 0.130 |
Why?
|
Cyclic AMP | 2 | 1992 | 1467 | 0.130 |
Why?
|
Receptors, Cell Surface | 2 | 2003 | 2815 | 0.130 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 4 | 1998 | 19 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2879 | 0.130 |
Why?
|
bcl-2-Associated X Protein | 1 | 2017 | 282 | 0.130 |
Why?
|
Tetrodotoxin | 1 | 1997 | 244 | 0.130 |
Why?
|
Flagellin | 1 | 2016 | 124 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 1997 | 216 | 0.130 |
Why?
|
Thimerosal | 1 | 1995 | 15 | 0.130 |
Why?
|
Chemokines | 1 | 2020 | 959 | 0.120 |
Why?
|
Polymerase Chain Reaction | 4 | 2003 | 6057 | 0.120 |
Why?
|
Hydroquinones | 1 | 1995 | 34 | 0.120 |
Why?
|
Sodium Channels | 1 | 1997 | 339 | 0.120 |
Why?
|
Calcium-Transporting ATPases | 1 | 1995 | 122 | 0.120 |
Why?
|
Decidua | 1 | 2015 | 80 | 0.120 |
Why?
|
Ovariectomy | 1 | 2017 | 612 | 0.120 |
Why?
|
Mice, Inbred Strains | 1 | 2017 | 1769 | 0.120 |
Why?
|
Phosphatidylinositols | 4 | 1997 | 276 | 0.110 |
Why?
|
Toll-Like Receptor 4 | 3 | 2009 | 588 | 0.110 |
Why?
|
Cell-Free System | 1 | 2014 | 339 | 0.110 |
Why?
|
Vitamins | 1 | 2022 | 1631 | 0.110 |
Why?
|
Calcium Channel Blockers | 1 | 1997 | 686 | 0.110 |
Why?
|
Testosterone | 4 | 1993 | 2495 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 548 | 0.110 |
Why?
|
Quinolines | 1 | 2018 | 769 | 0.110 |
Why?
|
Norepinephrine | 6 | 1989 | 898 | 0.110 |
Why?
|
Genitalia, Male | 1 | 1993 | 87 | 0.110 |
Why?
|
Receptors, Adrenergic | 1 | 1993 | 155 | 0.110 |
Why?
|
Fetal Development | 1 | 2018 | 777 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2000 | 3722 | 0.100 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3692 | 0.100 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2510 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2003 | 3606 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2014 | 3077 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2000 | 10737 | 0.090 |
Why?
|
Immunity | 1 | 2017 | 1001 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2022 | 3140 | 0.090 |
Why?
|
Pregnancy Complications | 6 | 1989 | 2970 | 0.090 |
Why?
|
Thrombomodulin | 1 | 2011 | 107 | 0.090 |
Why?
|
Hirudins | 2 | 2002 | 179 | 0.090 |
Why?
|
Cricetinae | 5 | 1993 | 2413 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1999 | 2425 | 0.090 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2011 | 279 | 0.090 |
Why?
|
Calcium Channel Agonists | 2 | 2000 | 26 | 0.090 |
Why?
|
Immunization | 1 | 2014 | 1218 | 0.080 |
Why?
|
Reference Values | 3 | 2001 | 4909 | 0.080 |
Why?
|
Phenanthrolines | 1 | 2009 | 48 | 0.080 |
Why?
|
Adrenergic Agonists | 1 | 1989 | 56 | 0.080 |
Why?
|
Anthraquinones | 1 | 2009 | 41 | 0.080 |
Why?
|
Adaptive Immunity | 1 | 2014 | 733 | 0.080 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1989 | 171 | 0.080 |
Why?
|
Influenza in Birds | 1 | 2009 | 76 | 0.080 |
Why?
|
Chromaffin System | 3 | 1983 | 15 | 0.080 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 2 | 1999 | 89 | 0.080 |
Why?
|
Endoplasmic Reticulum | 1 | 1995 | 1132 | 0.080 |
Why?
|
Birds | 1 | 2009 | 165 | 0.080 |
Why?
|
Humans | 40 | 2022 | 766019 | 0.080 |
Why?
|
Endometrium | 2 | 2002 | 404 | 0.080 |
Why?
|
Cell Line | 4 | 2016 | 15545 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2000 | 1724 | 0.070 |
Why?
|
Stilbenes | 1 | 2009 | 154 | 0.070 |
Why?
|
Phosphotyrosine | 1 | 2009 | 459 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2002 | 2270 | 0.070 |
Why?
|
Hospitals, Maternity | 2 | 1990 | 31 | 0.070 |
Why?
|
Pregnancy in Diabetics | 5 | 1989 | 198 | 0.070 |
Why?
|
Oscillometry | 2 | 1999 | 151 | 0.070 |
Why?
|
Hydrocortisone | 2 | 1992 | 1832 | 0.070 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 1998 | 222 | 0.070 |
Why?
|
Phosphorylation | 2 | 2009 | 8290 | 0.070 |
Why?
|
DNA, Complementary | 2 | 2009 | 1984 | 0.070 |
Why?
|
Influenza Vaccines | 1 | 2014 | 780 | 0.070 |
Why?
|
Immunosorbent Techniques | 1 | 2006 | 174 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1890 | 0.070 |
Why?
|
Infant, Newborn | 12 | 2022 | 26379 | 0.070 |
Why?
|
Phosphoinositide Phospholipase C | 2 | 1998 | 28 | 0.070 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2006 | 121 | 0.070 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 97 | 0.060 |
Why?
|
Myositis | 1 | 1989 | 271 | 0.060 |
Why?
|
Infant Mortality | 3 | 1990 | 752 | 0.060 |
Why?
|
Protein Array Analysis | 1 | 2007 | 398 | 0.060 |
Why?
|
Dermatomyositis | 1 | 1989 | 261 | 0.060 |
Why?
|
Indomethacin | 2 | 2001 | 322 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1467 | 0.060 |
Why?
|
Inositol 1,4,5-Trisphosphate | 2 | 1995 | 110 | 0.060 |
Why?
|
Prazosin | 3 | 1991 | 95 | 0.060 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 453 | 0.060 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2006 | 225 | 0.060 |
Why?
|
Organometallic Compounds | 1 | 2009 | 645 | 0.060 |
Why?
|
Time Factors | 7 | 2009 | 40100 | 0.060 |
Why?
|
Cell Movement | 1 | 2017 | 5194 | 0.060 |
Why?
|
Epinephrine | 3 | 1989 | 782 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7426 | 0.060 |
Why?
|
Carboprost | 1 | 1984 | 3 | 0.060 |
Why?
|
Protein Isoforms | 2 | 2006 | 1715 | 0.060 |
Why?
|
Prostaglandins F, Synthetic | 1 | 1984 | 32 | 0.060 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2003 | 18 | 0.060 |
Why?
|
Adrenal Medulla | 1 | 1983 | 56 | 0.050 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1695 | 0.050 |
Why?
|
Uterine Diseases | 1 | 1984 | 108 | 0.050 |
Why?
|
Sphingomyelins | 2 | 1986 | 103 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22339 | 0.050 |
Why?
|
Macrophages | 2 | 2017 | 5775 | 0.050 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2003 | 282 | 0.050 |
Why?
|
Snake Venoms | 1 | 2002 | 40 | 0.050 |
Why?
|
Rabbits | 4 | 1997 | 4730 | 0.050 |
Why?
|
Hospitals, Special | 1 | 1982 | 88 | 0.050 |
Why?
|
Factor V | 1 | 2002 | 168 | 0.050 |
Why?
|
Tocolytic Agents | 1 | 2001 | 24 | 0.050 |
Why?
|
Cesarean Section | 6 | 1986 | 1418 | 0.050 |
Why?
|
Phosphatidylcholines | 2 | 1986 | 403 | 0.050 |
Why?
|
Antithrombin III | 1 | 2001 | 128 | 0.050 |
Why?
|
Factor Xa | 1 | 2002 | 165 | 0.050 |
Why?
|
Proteins | 2 | 1997 | 5994 | 0.050 |
Why?
|
Mesocricetus | 2 | 1993 | 256 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2003 | 1546 | 0.050 |
Why?
|
Veins | 1 | 1985 | 769 | 0.050 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2000 | 29 | 0.050 |
Why?
|
Transcription Factors | 1 | 2000 | 12128 | 0.050 |
Why?
|
Puerperal Disorders | 1 | 1984 | 304 | 0.050 |
Why?
|
Vas Deferens | 2 | 1992 | 55 | 0.050 |
Why?
|
Okadaic Acid | 1 | 2000 | 67 | 0.050 |
Why?
|
Blood Physiological Phenomena | 1 | 2000 | 53 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 2003 | 4163 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1989 | 2205 | 0.040 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1980 | 42 | 0.040 |
Why?
|
Indoles | 1 | 2009 | 1833 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 11906 | 0.040 |
Why?
|
Peptide Termination Factors | 1 | 2000 | 56 | 0.040 |
Why?
|
Sympathetic Nervous System | 1 | 1983 | 520 | 0.040 |
Why?
|
Isoproterenol | 2 | 1992 | 398 | 0.040 |
Why?
|
Models, Animal | 1 | 2007 | 2120 | 0.040 |
Why?
|
Infant | 2 | 2022 | 36424 | 0.040 |
Why?
|
Diacylglycerol Kinase | 1 | 2000 | 47 | 0.040 |
Why?
|
Cyclohexanones | 1 | 2000 | 30 | 0.040 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2000 | 122 | 0.040 |
Why?
|
Arteries | 1 | 1985 | 1121 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3801 | 0.040 |
Why?
|
Protein Phosphatase 1 | 1 | 2000 | 135 | 0.040 |
Why?
|
Hemangioma, Cavernous | 1 | 1980 | 106 | 0.040 |
Why?
|
Lipoprotein Lipase | 1 | 2000 | 133 | 0.040 |
Why?
|
Prenatal Diagnosis | 3 | 1985 | 1271 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2000 | 148 | 0.040 |
Why?
|
Sulfonamides | 1 | 2009 | 1980 | 0.040 |
Why?
|
Heparin | 2 | 2002 | 1635 | 0.040 |
Why?
|
Blood | 1 | 2001 | 597 | 0.040 |
Why?
|
Genital Neoplasms, Male | 2 | 1989 | 68 | 0.040 |
Why?
|
Sexual Maturation | 1 | 2000 | 256 | 0.040 |
Why?
|
Aging | 2 | 2017 | 8723 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2001 | 608 | 0.040 |
Why?
|
Clonidine | 2 | 1990 | 170 | 0.040 |
Why?
|
Prostaglandins | 2 | 2015 | 396 | 0.040 |
Why?
|
Phentolamine | 2 | 1989 | 102 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2743 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 1991 | 858 | 0.040 |
Why?
|
Pyrazoles | 1 | 2009 | 2031 | 0.040 |
Why?
|
Up-Regulation | 1 | 2007 | 4133 | 0.040 |
Why?
|
Fetal Blood | 2 | 1985 | 1365 | 0.040 |
Why?
|
Organ Specificity | 1 | 2003 | 1966 | 0.040 |
Why?
|
Imidazolines | 1 | 1997 | 18 | 0.040 |
Why?
|
Sequence Homology | 1 | 1998 | 197 | 0.040 |
Why?
|
Antithrombins | 1 | 2000 | 294 | 0.040 |
Why?
|
Delivery, Obstetric | 2 | 2001 | 948 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 2000 | 433 | 0.040 |
Why?
|
Binding, Competitive | 2 | 1991 | 1140 | 0.040 |
Why?
|
Ion Transport | 1 | 1998 | 322 | 0.040 |
Why?
|
Base Sequence | 4 | 2009 | 12405 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2000 | 384 | 0.040 |
Why?
|
Propranolol | 2 | 1989 | 493 | 0.040 |
Why?
|
Hypoglycemia | 2 | 1983 | 896 | 0.040 |
Why?
|
Fura-2 | 1 | 1997 | 107 | 0.030 |
Why?
|
Analysis of Variance | 2 | 1996 | 6208 | 0.030 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 1998 | 185 | 0.030 |
Why?
|
Ionophores | 1 | 1997 | 108 | 0.030 |
Why?
|
Maternal Mortality | 1 | 1980 | 310 | 0.030 |
Why?
|
Immune Sera | 1 | 1997 | 601 | 0.030 |
Why?
|
Pyrimidines | 1 | 2009 | 3050 | 0.030 |
Why?
|
Receptors, Muscarinic | 1 | 1997 | 156 | 0.030 |
Why?
|
Genes, Regulator | 1 | 1997 | 373 | 0.030 |
Why?
|
Receptors, Prostaglandin | 1 | 1996 | 54 | 0.030 |
Why?
|
Egtazic Acid | 1 | 1996 | 165 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 1989 | 3269 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2003 | 1245 | 0.030 |
Why?
|
Epithelium | 1 | 2000 | 1604 | 0.030 |
Why?
|
Postpartum Period | 1 | 2003 | 1195 | 0.030 |
Why?
|
Fetal Diseases | 4 | 1985 | 915 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1995 | 303 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 1989 | 3928 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 4779 | 0.030 |
Why?
|
Cell Membrane | 2 | 1999 | 3635 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 3112 | 0.030 |
Why?
|
Leiomyosarcoma | 2 | 1989 | 425 | 0.030 |
Why?
|
Metabolic Clearance Rate | 2 | 1985 | 361 | 0.030 |
Why?
|
Stromal Cells | 1 | 2000 | 1332 | 0.030 |
Why?
|
Inositol | 1 | 1995 | 215 | 0.030 |
Why?
|
Calcium Channels, L-Type | 1 | 1996 | 243 | 0.030 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 1994 | 40 | 0.030 |
Why?
|
Adult | 13 | 2022 | 223110 | 0.030 |
Why?
|
Half-Life | 2 | 1985 | 645 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 4 | 1986 | 518 | 0.030 |
Why?
|
Calcium Signaling | 1 | 1998 | 734 | 0.030 |
Why?
|
Cycloheximide | 2 | 1991 | 339 | 0.030 |
Why?
|
Macaca mulatta | 3 | 1985 | 2341 | 0.030 |
Why?
|
Extracellular Space | 1 | 1995 | 563 | 0.030 |
Why?
|
Sympatholytics | 1 | 1993 | 82 | 0.030 |
Why?
|
Sympathomimetics | 1 | 1993 | 56 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 29905 | 0.030 |
Why?
|
Lung | 3 | 2007 | 10061 | 0.030 |
Why?
|
Fetal Organ Maturity | 2 | 1983 | 83 | 0.030 |
Why?
|
Kidney | 2 | 2007 | 7072 | 0.030 |
Why?
|
Thiazoles | 1 | 2000 | 1528 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5695 | 0.030 |
Why?
|
Isoelectric Point | 1 | 1992 | 76 | 0.020 |
Why?
|
Theophylline | 1 | 1992 | 132 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 283 | 0.020 |
Why?
|
Liver | 1 | 2007 | 7558 | 0.020 |
Why?
|
Polyribosomes | 1 | 1991 | 109 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 1989 | 6101 | 0.020 |
Why?
|
Amniocentesis | 2 | 1982 | 116 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13400 | 0.020 |
Why?
|
Models, Biological | 2 | 1998 | 9446 | 0.020 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 1992 | 205 | 0.020 |
Why?
|
Dactinomycin | 1 | 1991 | 304 | 0.020 |
Why?
|
Ethanol | 1 | 1997 | 1326 | 0.020 |
Why?
|
RNA | 1 | 2000 | 2715 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2077 | 0.020 |
Why?
|
Adenine | 1 | 1996 | 994 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 17597 | 0.020 |
Why?
|
Yohimbine | 1 | 1989 | 63 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2161 | 0.020 |
Why?
|
Chicago | 1 | 1990 | 255 | 0.020 |
Why?
|
Genes, RAG-1 | 1 | 2009 | 67 | 0.020 |
Why?
|
Home Childbirth | 1 | 1989 | 55 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 1997 | 1927 | 0.020 |
Why?
|
Enzyme Activation | 1 | 1994 | 3584 | 0.020 |
Why?
|
Ribosomes | 1 | 1991 | 495 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 1991 | 910 | 0.020 |
Why?
|
Dihydroergotoxine | 1 | 1987 | 21 | 0.020 |
Why?
|
Hospitals, Community | 1 | 1990 | 363 | 0.020 |
Why?
|
Apomorphine | 1 | 1987 | 148 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 74837 | 0.020 |
Why?
|
Fetal Death | 3 | 1986 | 434 | 0.020 |
Why?
|
Diabetic Nephropathies | 2 | 1986 | 968 | 0.020 |
Why?
|
Infant, Low Birth Weight | 2 | 1990 | 870 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1990 | 2543 | 0.020 |
Why?
|
Calcitonin | 1 | 1968 | 326 | 0.020 |
Why?
|
Kinetics | 2 | 1991 | 6273 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2009 | 827 | 0.020 |
Why?
|
Infant, Premature | 2 | 1989 | 2121 | 0.020 |
Why?
|
Thrombophlebitis | 1 | 1985 | 289 | 0.020 |
Why?
|
Erythroblastosis, Fetal | 2 | 1985 | 62 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 1990 | 703 | 0.010 |
Why?
|
Procainamide | 1 | 1984 | 56 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1997 | 4910 | 0.010 |
Why?
|
Prednisone | 1 | 1989 | 1566 | 0.010 |
Why?
|
Insulin Infusion Systems | 1 | 1985 | 221 | 0.010 |
Why?
|
Receptor, PAR-2 | 1 | 2003 | 33 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1991 | 2091 | 0.010 |
Why?
|
Diabetes Insipidus | 1 | 1984 | 143 | 0.010 |
Why?
|
Methods | 1 | 1984 | 1061 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 1985 | 457 | 0.010 |
Why?
|
3-Methoxy-4-hydroxyphenylethanol | 1 | 1982 | 2 | 0.010 |
Why?
|
Pargyline | 1 | 1982 | 19 | 0.010 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 1982 | 60 | 0.010 |
Why?
|
Homovanillic Acid | 1 | 1982 | 73 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 1986 | 538 | 0.010 |
Why?
|
Actins | 1 | 1990 | 2061 | 0.010 |
Why?
|
Cervix Mucus | 1 | 1982 | 18 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1982 | 199 | 0.010 |
Why?
|
Xenopus laevis | 2 | 2000 | 965 | 0.010 |
Why?
|
Cefoxitin | 1 | 1982 | 36 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1982 | 289 | 0.010 |
Why?
|
Uterine Hemorrhage | 1 | 1984 | 235 | 0.010 |
Why?
|
Puerperal Infection | 1 | 1982 | 46 | 0.010 |
Why?
|
Tritium | 1 | 1982 | 702 | 0.010 |
Why?
|
Tachycardia | 1 | 1984 | 598 | 0.010 |
Why?
|
Fetal Heart | 1 | 1983 | 281 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14644 | 0.010 |
Why?
|
Edema | 1 | 1985 | 763 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1623 | 0.010 |
Why?
|
Ultrasonography | 3 | 1985 | 5988 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1986 | 649 | 0.010 |
Why?
|
Blood Vessel Prosthesis | 1 | 1986 | 956 | 0.010 |
Why?
|
Blood Transfusion, Intrauterine | 1 | 1980 | 28 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1980 | 5836 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 2000 | 211 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1983 | 556 | 0.010 |
Why?
|
Twins | 1 | 1982 | 340 | 0.010 |
Why?
|
Templates, Genetic | 1 | 2000 | 188 | 0.010 |
Why?
|
Codon, Terminator | 1 | 2000 | 125 | 0.010 |
Why?
|
Body Temperature | 1 | 1983 | 781 | 0.010 |
Why?
|
Postpartum Hemorrhage | 1 | 1984 | 275 | 0.010 |
Why?
|
Molecular Mimicry | 1 | 2000 | 210 | 0.010 |
Why?
|
Patient Compliance | 1 | 1990 | 2694 | 0.010 |
Why?
|
Thermodynamics | 1 | 2000 | 577 | 0.010 |
Why?
|
Prenatal Care | 2 | 1986 | 1158 | 0.010 |
Why?
|
RNA Stability | 1 | 2000 | 319 | 0.010 |
Why?
|
Boston | 2 | 1982 | 9335 | 0.010 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1980 | 239 | 0.010 |
Why?
|
Intraoperative Care | 1 | 1982 | 768 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1985 | 1145 | 0.010 |
Why?
|
Capsid | 1 | 2000 | 435 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1990 | 3560 | 0.010 |
Why?
|
Recurrence | 3 | 1986 | 8494 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1986 | 1464 | 0.010 |
Why?
|
Tropomyosin | 1 | 1997 | 103 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 1982 | 587 | 0.010 |
Why?
|
GTP Phosphohydrolases | 1 | 2000 | 524 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 2000 | 899 | 0.010 |
Why?
|
Vagina | 1 | 1982 | 849 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9540 | 0.010 |
Why?
|
Receptors, Leptin | 1 | 1997 | 352 | 0.010 |
Why?
|
Male | 9 | 1993 | 363880 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2009 | 4783 | 0.010 |
Why?
|
Patient Admission | 1 | 1982 | 1364 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1989 | 3445 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1990 | 18965 | 0.010 |
Why?
|
Syndrome | 1 | 1980 | 3270 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1997 | 1885 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14457 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 18075 | 0.010 |
Why?
|
DNA Primers | 1 | 1997 | 2823 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1985 | 5125 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1990 | 9237 | 0.010 |
Why?
|
Thrombosis | 1 | 1986 | 2953 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 1985 | 2596 | 0.010 |
Why?
|
RNA, Viral | 1 | 2000 | 2868 | 0.010 |
Why?
|
Ornithine Decarboxylase | 1 | 1991 | 63 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1991 | 220 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10260 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1986 | 4277 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1991 | 848 | 0.010 |
Why?
|
Risk | 1 | 1982 | 9598 | 0.010 |
Why?
|
Blood Glucose | 2 | 1985 | 6420 | 0.010 |
Why?
|
Fertilization | 1 | 1991 | 197 | 0.010 |
Why?
|
Polyhydramnios | 1 | 1989 | 41 | 0.010 |
Why?
|
Leptin | 1 | 1997 | 1596 | 0.010 |
Why?
|
Fetal Macrosomia | 1 | 1989 | 138 | 0.000 |
Why?
|
Prostaglandins F | 1 | 1988 | 79 | 0.000 |
Why?
|
Protein Binding | 1 | 2000 | 9302 | 0.000 |
Why?
|
Castration | 1 | 1968 | 149 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1968 | 551 | 0.000 |
Why?
|
Insulin | 1 | 1981 | 6603 | 0.000 |
Why?
|
Plasmids | 1 | 1991 | 2266 | 0.000 |
Why?
|
Kell Blood-Group System | 1 | 1985 | 21 | 0.000 |
Why?
|
Androstenedione | 1 | 1985 | 138 | 0.000 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 1985 | 83 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1985 | 395 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1968 | 1376 | 0.000 |
Why?
|
Dihydrotestosterone | 1 | 1985 | 194 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1986 | 15804 | 0.000 |
Why?
|
Drug Synergism | 1 | 1968 | 1753 | 0.000 |
Why?
|
Sex Factors | 2 | 1985 | 10611 | 0.000 |
Why?
|
Endometritis | 1 | 1982 | 49 | 0.000 |
Why?
|
Apgar Score | 1 | 1982 | 125 | 0.000 |
Why?
|
Aortic Valve Insufficiency | 1 | 1986 | 575 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1991 | 6492 | 0.000 |
Why?
|
United States | 1 | 1989 | 72918 | 0.000 |
Why?
|
Pregnancy Trimester, First | 1 | 1985 | 917 | 0.000 |
Why?
|
Fetal Growth Retardation | 1 | 1985 | 591 | 0.000 |
Why?
|
Diabetic Angiopathies | 1 | 1986 | 805 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1986 | 1109 | 0.000 |
Why?
|
Pre-Eclampsia | 1 | 1989 | 1257 | 0.000 |
Why?
|
Ascites | 1 | 1980 | 336 | 0.000 |
Why?
|
Proteinuria | 1 | 1981 | 606 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1989 | 2969 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1985 | 1794 | 0.000 |
Why?
|
Random Allocation | 1 | 1982 | 2395 | 0.000 |
Why?
|
Pregnancy Trimester, Second | 1 | 1980 | 737 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1991 | 7599 | 0.000 |
Why?
|
Bone and Bones | 1 | 1968 | 2555 | 0.000 |
Why?
|
Hyperglycemia | 1 | 1985 | 1389 | 0.000 |
Why?
|
Fluoroscopy | 1 | 1980 | 945 | 0.000 |
Why?
|
Aortic Valve | 1 | 1986 | 1964 | 0.000 |
Why?
|
Creatinine | 1 | 1981 | 1916 | 0.000 |
Why?
|
Urinary Tract Infections | 1 | 1982 | 804 | 0.000 |
Why?
|
Postoperative Care | 1 | 1982 | 1475 | 0.000 |
Why?
|
Fever | 1 | 1982 | 1607 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1985 | 5301 | 0.000 |
Why?
|
Hypertension | 2 | 1986 | 8609 | 0.000 |
Why?
|
Hemorrhage | 1 | 1985 | 3464 | 0.000 |
Why?
|
Birth Weight | 1 | 1981 | 2122 | 0.000 |
Why?
|
Echocardiography | 1 | 1984 | 5033 | 0.000 |
Why?
|
Age Factors | 1 | 1968 | 18382 | 0.000 |
Why?
|
Child Development | 1 | 1981 | 2327 | 0.000 |
Why?
|
Sepsis | 1 | 1982 | 2604 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1982 | 8037 | 0.000 |
Why?
|
Retrospective Studies | 2 | 1986 | 81544 | 0.000 |
Why?
|
Child, Preschool | 1 | 1981 | 42509 | 0.000 |
Why?
|
Prospective Studies | 1 | 1982 | 54804 | 0.000 |
Why?
|
Adolescent | 1 | 1985 | 88808 | 0.000 |
Why?
|
Child | 1 | 1981 | 80567 | 0.000 |
Why?
|